Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Hypertens Res ; 43(6): 511-517, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32042143

RESUMEN

MicroRNAs are key molecules involved in the regulation of endothelial function. They are important risk factors and biomarkers for the development of hypertension related to endothelial dysfunction. However, the gene expression patterns associated with hypertension development related to endothelial dysfunction have not been fully elucidated. We conducted a case-control study of 65 patients with essential hypertension (EH) and 61 controls without EH. Plasma levels of miR-122 and its target protein high-affinity cationic amino acid transporter 1 (CAT-1) were measured by qRT-PCR and ELISA, respectively. miR-122 expression in plasma of patients with EH was significantly higher than that of the control group (p = 0.001), while CAT-1 expression in patients with EH was significantly lower than that in the control group (p = 0.018). miR-122 expression in plasma of young patients with EH was significantly higher than that in young people without EH (p = 0.0004), and CAT-1 expression in plasma of young patients with EH was also significantly lower than that of the control group (p = 0.002). CAT-1 expression in the plasma of young participants was significantly higher than that of individuals aged ≥40 years (p = 0.003), whereas miR-122 expression was significantly lower (p = 0.001). We showed that among patients with EH, the high expression of miR-122 contributed to endothelial dysfunction by suppressing the expression of the CAT-1 protein, which led to a decrease in CAT-1 expression in plasma. Therefore, high expression of miR-122 appears to be a risk factor for endothelial dysfunction in EH, especially in younger patients.


Asunto(s)
Endotelio Vascular/fisiopatología , Hipertensión Esencial/sangre , MicroARNs/sangre , Adolescente , Adulto , Biomarcadores/sangre , Estudios de Casos y Controles , Hipertensión Esencial/fisiopatología , Femenino , Proteínas Activadoras de GTPasa/sangre , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Adulto Joven
2.
Zhonghua Zheng Xing Wai Ke Za Zhi ; 19(2): 110-1, 2003 Mar.
Artículo en Chino | MEDLINE | ID: mdl-12889188

RESUMEN

OBJECTIVE: To introduce the experience of correcting the congenital ala defect of facial cleft with the method of revolving reposition. METHODS: Five patients were treated with this method. Based on features of the defect, two different operations were employed with the medial crura or the lateral crura of the ala as the revolving pivot. RESULTS: All the operations obtained good results. CONCLUSION: The operation of revolving reposition for congenital ala defect is a simple practical method with satisfactory results.


Asunto(s)
Labio Leporino/cirugía , Cara/anomalías , Cara/cirugía , Procedimientos de Cirugía Plástica/métodos , Niño , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA